Latest news with #TEER
Mint
21-07-2025
- Business
- Mint
ADIA to Invest USD 200 Million in Meril
Vapi, India– [21 July 2025] – A wholly owned subsidiary of the Abu Dhabi Investment Authority ('ADIA') has entered into definitive agreements to invest USD 200 million for a ~3% stake in Micro Life Sciences Private Limited ('Meril'), one of India's leading medical devices companies. This investment values Meril at an enterprise value of USD 6.6 billion. The transaction is subject to regulatory approval by the Competition Commission of India (CCI). Post this investment, Meril will be backed by two globally recognized investors, ADIA and Warburg Pincus. Founded by the Bilakhia Group, Meril is a global innovator in medical technology (MedTech), with a strong focus on clinically advanced solutions across multiple specialties — including Cardiovascular, Structural Heart, Orthopaedics, Endo-surgery, In-vitro Diagnostics and Surgical Robotics. Headquartered in Vapi, India, Meril operates state-of-the-art, vertically integrated, and globally certified manufacturing and R&D facilities, across a 100 acre sustainable MedTech campus. The company employs more than 13,000 people, has 35+ global subsidiaries, and serves healthcare systems in 150+ countries. Meril is committed to becoming the world's leading MedTech company, powered 100% by green energy, reinforcing its commitment to sustainable innovation. Meril With a robust in-house global R&D ecosystem and a portfolio of 200+ technology platforms, Meril continues to lead in global clinical research and education. Breakthrough innovations such as the Myval Transcatheter Heart Valve (THV) series, MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System highlight Meril's dedication to next-generation innovation. Through its 12+ global training academies, Meril empowers over 10,000 healthcare professionals annually. Sanjeev Bhatt, Senior Vice President – Strategy, Meril said: 'This investment by ADIA reinforces confidence in Meril's long term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our R&D and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Meril is a global medical technology company headquartered in Vapi, India. With a strong emphasis on innovation, Meril develops clinically meaningful products aimed at enhancing patient outcomes across cardiovascular, orthopaedic, diagnostic, Endo Surgery and robotic surgery domains. Founded by the Bilakhia Group, the company is committed to sustainability, quality, and global impact. For more information: About Abu Dhabi Investment Authority (ADIA) Established in 1976, the Abu Dhabi Investment Authority ('ADIA') is a globally-diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long-term value creation. For more information: Media contact :media@ Note to readers: This article is part of Mint's paid consumer connect Initiative. Mint assumes no editorial involvement or responsibility for errors, omissions, or content accuracy. Want to get your story featured as above?click here!
Al Etihad
21-07-2025
- Business
- Al Etihad
ADIA to invest $200 million in Indian medical devices company
21 July 2025 11:27 A. SREENIVASA REDDY (ABU DHABI)A wholly owned subsidiary of the Abu Dhabi Investment Authority (ADIA) has entered into a definitive agreement to invest $200 million for a 3% stake in Micro Life Sciences Private Limited (Meril), one of India's leading medical devices companies. This investment, which values Meril at an enterprise value of $6.6 billion, was confirmed in separate statements issued by both ADIA and transaction is subject to regulatory approval by India's Competition Commission. Once completed, it will result in Meril being backed by two globally recognised investors: ADIA and Warburg by the Bilakhia Group, Meril is headquartered in Vapi, in Gujarat province of India, and is a global innovator in the medical technology space. The company focuses on clinically advanced solutions across key healthcare domains, including cardiovascular, structural heart, orthopaedics, endo-surgery, in-vitro diagnostics, and surgical operations span more than 150 countries and are supported by a network of 35+ global subsidiaries. Its vertically integrated and globally certified manufacturing and research facilities are spread across a 100-acre sustainable MedTech campus. Employing over 13,000 people, Meril powers its operations entirely with green energy and runs more than 12 global training academies that reach over 10,000 healthcare professionals product innovations include the Myval Transcatheter Heart Valve (THV) series, the MyClip Transcatheter Edge-to-Edge Repair (TEER) system, and the MISSO Surgical Robotic System. The company holds a portfolio of over 200 technology platforms and maintains a strong in-house ecosystem for global research, clinical trials, and on the deal, Sanjeev Bhatt, Senior Vice President – Strategy at Meril, said, 'This investment by ADIA reinforces confidence in Meril's long-term vision and global ambitions. This investment will enable us to accelerate growth, attract world-class talent, and further strengthen our RCD and clinical research efforts as we work towards improving the quality of human life through advanced healthcare solutions.' Established in 1976, ADIA is a globally diversified investment institution that prudently invests funds on behalf of the Government of Abu Dhabi through a strategy focused on long‑term value creation.
BBC News
04-06-2025
- General
- BBC News
County Durham women first in North East to have heart procedure
A patient who was one of a region's first to have a new heart procedure says it helped her get her life Wells, from Peterlee, and Lindel Carre, from Durham, were the first in north-east England to receive a tricuspid transcatheter edge-to-edge repair (TEER), at Middlesbrough's James Cook University is designed to treat tricuspid regurgitation, a condition where one of the heart's valves becomes leaky, causing fatigue, leg swelling, and breathlessness. Ms Wells said she felt she "didn't have a life" before the procedure but she "didn't think that way now – that's the difference it's made to me". The retired nurse previously had a successful mitral valve replacement using open heart surgery in 2021. However, she began experiencing increasing breathlessness in recent years."Leading up to Christmas, I was wrapping presents with family, and I was thinking 'this is the last time I'm going to be doing this'," she said."I could barely walk three or four steps without having to stop to get my breath back." Tricuspid regurgitation is usually difficult to manage with medication alone and open heart surgery can be too high risk for older is a safer alternative and involves inserting a small clip through a vein in the groin to reduce the leak in the valve. 'Incredibly rewarding' Ms Wells and Ms Carre had the procedure on 6 Carre, 83, said she saw a lot of improvements almost straight retired teacher had been suffering with the heaviness of her legs caused by her worsening valve condition. "I have much more energy, no breathlessness, and I can drive further than I could before – I'm more confident and more independent," she procedures were performed by the hospital's TEER team, led by cardiology consultants Paul Williams, Seth Vijayan and Richard Williams said it was "incredibly rewarding" to see patients experience such an improvement in their quality of life. Follow BBC North East on X, Facebook, Nextdoor and Instagram.
